News Briefs

Some health insurers received and then returned unsolicited payments from the $30 billion grant fund that HHS distributed to offer COVID-19 financial relief to health care providers, Modern Healthcare reported. UnitedHealth Group received and returned $49 million, Cigna Corp. returned $41 million, and CVS Health Corp., which owns Aetna, received and returned $43 million. Humana Inc. and Centene Corp. also told Modern Healthcare that they returned some relief funding, though they did not disclose how much. Read the article at https://bit.ly/2Xa9FZv.

CVS Health Corp. is being sued by six Blue Cross Blue Shield plans that claim CVS “intentionally engaged in a fraudulent scheme” to overcharge them for prescription drugs by “submitting claims for payment at artificially inflated prices.” The lawsuit claims CVS “intentionally told third-party payors, including Plaintiffs, that the prices charged to cash customers for …generic drugs were higher — often much higher,” than they actually were. “Third-party payors then reimbursed CVS based on those higher, inflated prices — instead of the actual, lower, prices CVS offered to the general public, including through its Cash Discount Programs.” CVS is disputing the claims. View the lawsuit at https://go.aws/36FfpO5.

0 Comments
© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured-Image-radar-on-drug-benefits-COVID-19-Treatment-Candidates-at-a-Glance.jpg
December 3

Health Insurers Embrace Vaccine Requirements for Workers

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured_AdobeStock_23041642.jpg
December 3

TeamHealth Wins One Battle in Ongoing War With UnitedHealth

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg
December 3

Optum Dominates UnitedHealth’s Investor Day, Growth Strategy

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today